Geode Capital Management’s Envue Medical FEED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-1,289
| Closed | -$7.96K | – | 4470 |
|
|
2026
Q2 | $7.96K | Sell |
1,289
-579
| -31% | -$7.85K | ﹤0.01% | 4435 |
|
|
2026
Q1 | $53.4K | Buy |
+1,868
| New | +$48.5K | ﹤0.01% | 4295 |
|
|
2025
Q1 | – | Sell |
-17
| Closed | -$13.4K | – | 4497 |
|
|
2024
Q4 | $13.4K | Hold |
17
| – | – | ﹤0.01% | 4420 |
|
|
2024
Q3 | $14K | Sell |
17
-1
| -6% | -$873 | ﹤0.01% | 4437 |
|
|
2024
Q2 | $16.2K | Buy |
18
+7
| +64% | +$7.15K | ﹤0.01% | 4483 |
|
|
2024
Q1 | $13K | Hold |
11
| – | – | ﹤0.01% | 4531 |
|
|
2023
Q4 | $16.6K | Hold |
11
| – | – | ﹤0.01% | 4543 |
|
|
2023
Q3 | $28.5K | Buy |
11
+3
| +38% | +$10.7K | ﹤0.01% | 4552 |
|
|
2023
Q2 | $36.7K | Hold |
8
| – | – | ﹤0.01% | 4570 |
|
|
2023
Q1 | $36.2K | Hold |
8
| – | – | ﹤0.01% | 4590 |
|
|
2022
Q4 | $54K | Hold |
8
| – | – | ﹤0.01% | 4573 |
|
|
2022
Q3 | $95K | Hold |
8
| – | – | ﹤0.01% | 4596 |
|
|
2022
Q2 | $127K | Buy |
8
+1
| +14% | +$18.9K | ﹤0.01% | 4488 |
|
|
2022
Q1 | $228K | Hold |
7
| – | – | ﹤0.01% | 4310 |
|
|
2021
Q4 | $205K | Sell |
7
-1
| -13% | -$35.7K | ﹤0.01% | 4462 |
|
|
2021
Q3 | $413K | Buy |
8
+3
| +60% | +$160K | ﹤0.01% | 4118 |
|
|
2021
Q2 | $116K | Buy |
5
+1
| +25% | +$24.3K | ﹤0.01% | 4516 |
|
|
2021
Q1 | $100K | Buy |
4
+3
| +300% | +$92.2K | ﹤0.01% | 4298 |
|
|
2020
Q4 | $19K | Buy |
+1
| New | +$19.6K | ﹤0.01% | 4250 |
|
Geode Capital Management's FEED Position: Q3 2026 in Review
Geode Capital Management sold out of Envue Medical (FEED) in Q3 2026, closing a stake of 1,289 shares — an estimated $7.96K sold.
Geode Capital Management first reported a position in FEED in Q4 2020 and held it in 19 quarters. The position peaked at $413K in Q3 2021. 0 funds tracked by Wall St. Rank hold FEED as of Q3 2026.
- Geode Capital Management reported no remaining Envue Medical position as of Q3 2026 after selling out during the quarter.
- Geode Capital Management sold 1,289 Envue Medical shares in Q3 2026, an estimated $7.96K.
- Geode Capital Management first reported a position in Envue Medical in Q4 2020 and held it in 19 quarters.
- Geode Capital Management's Envue Medical position peaked at $413K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Envue Medical as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.